VueReal Has Commenced Shipping High-Transparency and High-Resolution AM-MicroLED Displays Produced by VueReal MicroSolid Printing(TM) Platform to Its Partners

WATERLOO, ONTARIO, Dec 6, 2023 – (ACN Newswire) – VueReal celebrates a milestone in display technology, announcing the successful development and shipment of high-resolution and high-transparency microLED displays to its partners. The breakthrough comes courtesy of VueReal’s MicroSolid Printing™ Platform, addressing a pivotal challenge in MicroLED adoption – the efficient transfer of LEDs from wafer to backplane. Integrated into Active Matrix MicroLED displays, this achievement is set to reshape industries, introducing exceptional visual quality, energy efficiency, tunable transparency (80% to zero), and versatile applications.

 

VueReal Turnkey Platform

High-performing active matrix microLED display fabricated using VueReal Turnkey Platform

Key Highlights:

MicroLED Turnkey Platform:

The shipments underscore the capability and flexibility of VueReal’s MicroSolid Printing™ platform in developing a new display structure. More importantly, this turnkey platform showcases the success of fabricating and producing these unique displays, hitting a significant milestone in enabling mass market adoption of the MicroLED displays.

Enabling New Customers:

VueReal is actively inviting new customers to adopt MicroLED in their designs, offering access to the microLED platform. The company is now accepting new purchase orders for its newly developed high-resolution and high-transparency displays. Purchase orders will be evaluated based on business merits and the capability to integrate MicroLED into products, urging interested parties to provide detailed information about the business opportunities. Submit Your Order HERE.

VueReal Showcase at CES:

VueReal invites business leaders, industry professionals, and enthusiasts to explore its MicroLED displays and MicroSolid Printing technology at the upcoming Consumer Electronics Show (CES). The showcase promises insights into delivering the future of display technology today, highlighting the capabilities and advantages of VueReal’s MicroLED solutions. Submit CES 2024 Demo Request HERE.

Reza Chaji, CEO of VueReal, stated: “At VueReal, we envision MicroLED as the Next OLED in the $180 billion global display space. Our innovative mass-scale, low-cost, high-accuracy LED transfer process, aptly named MicroSolid Printing™, combined with our manufacturing display capabilities in Waterloo, Ontario, Canada, marks this vision’s realization.”

Mark Zeinstra, Vice President of Products, highlighted: “VueReal’s industry-leading MicroLED solutions create strong interest among our display, lighting, and sensor customers. Our customers are excited that VueReal technology makes the MicroLED’s advantages accessible. These features include improved reliability, packaging, brightness, low power, enhanced image quality, multi-functionality and transparency.”

About VueReal

VueReal, a leader in micro-pixel technology, stands at the forefront of innovation with a groundbreaking microLED transfer technology, MicroSolid Printing™. Leveraging its proprietary and cutting-edge MicroSolid Printing™ techniques, VueReal is poised to revolutionize the display landscape for several applications, including automotive, AR/VR, smartwatches, and smartphones. Its unique transfer technology is set to make developing groundbreaking and life-enhancing products as easy as software by facilitating scalable, cost-effective, and eco-friendly micro-pixel fabrication. To learn more, please follow VueReal at www.vuereal.com.

VueReal Communications
Sales: sales@vuereal.com
Investment: investment@vuereal.com

Contact Information
Reza Chaji
CEO
info@vuereal.com


Topic: Press release summary

Japan – Research commenced with Keio University to discover drugs using “Chemicals Informatics”

Hitachi High-Tech Solutions Corporation, in collaboration with Keio University Faculty of Pharmacy, Department of Pharmaceutical Sciences is commencing joint research that uses Materials Informatics (MI) (the Research) to improve the efficiency of the development of small molecule drugs(1).

Hitachi High-Tech Solutions will be using the “Chemicals Informatics (CI)” MI tool not only by developing materials in the traditional chemical materials field but also in the field of drug discovery, to improve quality of care and QoL (Quality of Life) for people.

Background to the Research

Small molecule drugs are mainstream drugs in the modern world, and in recent years, expectations for their use have increased, with the development of drugs such as molecular-targeted drugs that inhibit the action of proteins, which cause cancer(2). Traditionally, the process used to develop small molecule drugs has involved researchers using their knowledge and experience to select several potential compounds from an extensive library of existing compounds and then repeating experiments to adjust the structure of a compound and clarify the mechanism by which it will work, before moving on to clinical trial. As a result, more than a decade’s worth of R&D has been conducted at a huge cost, with a very low success rate. MI is expected to solve these challenges by using information science techniques, such as AI, to improve the efficiency of compound and material development.

Overview of the Research

In the Research, Keio University Faculty of Pharmacy, Department of Pharmaceutical Sciences will use Hitachi High-Tech Solutions’ CI to study the development of new drugs to act as selective inhibitors that will block enzymes that produce active sulfur molecules. We know that the production of a large quantity of active sulfur molecules in cells shows antioxidant effects, protein activity control and the generation of energy, etc. The development of small molecule drugs that inhibit the function of these enzymes is expected to lead to the elucidation of biological phenomena and the treatment of diseases such as cancer. The Research will use AI to conduct fast, comprehensive searches for promising compounds and potential structures based on the vast amount of data on compounds recorded in the CI, and then predict how the effects and mechanism will work using molecular dynamic simulations. This will help to improve the development of small molecule drugs in terms of a more efficient process, faster time scales and higher success rates, and will contribute to the development and early commercialization of new drugs.

Through this Research, Hitachi High-Tech Group will provide a practical demonstration of how CI, which to date has helped develop various materials in the chemical materials industry, can be applied to the development of pharmaceuticals and contribute to new drug development initiatives. In so doing, we will provide optimal solutions for creating social value and contribute to improving people’s QoL (Quality of Life).

(1) Small molecule drug: A type of drug that has very small (low weight) molecules that are able to easily enter cells.
(2) Molecular-targeted drugs: A therapeutic agent designed to act only on specific molecules that cause disease.

About Hitachi High-Tech

Hitachi High-Tech, headquartered in Tokyo, Japan, is engaged in activities in a broad range of fields, including manufacture and sales of clinical analyzers, biotechnology products, and analytical instruments, semiconductor manufacturing equipment and analysis equipment. and providing high value-added solutions in fields of social & industrial infrastructures and mobility, etc. The company’s consolidated revenues for FY 2021 were approx. JPY 576.8 billion [USD 5.1 billion]. For further information, visit www.hitachi-hightech.com/global/

Contact:
Kurokawa, Horiuchi
DX Marketing Dept., Corporate Strategy Div.,
Hitachi High-Tech Solutions Corporation
E-mail: hsl_marketing.dg@hitachi-hightech.com

Copyright ©2023 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Japan – Hitachi: Commenced Demonstration Operation of Cloud-based Advanced Energy Management System in Slovenia

New Energy and Industrial Technology Development Organization (NEDO) and Hitachi, Ltd., in cooperation with ELES, d.o.o., Slovenian national power transmission company, have completed “a cloud-based Advanced Energy Management System (AEMS)” which has been under construction since 2018 as the second phase of the smart community demonstration project and commenced its demonstration operation.

The storage batteries which were installed in the power distribution grid in the Idrija district

In this demonstration operation, we are aiming to establish an energy service business for large-scale power consumers and electric power retailers by building a cloud-based AEMS in the data center which has several functions such as, islanding (autonomous operation in the event of a power grid accident), voltage dips mitigation measures, and ancillary services (provision of flexibility to electricity transmission system operator).

Based on the analysis and evaluation results of the demonstration project, we will consider the development of the business model in the form of a service, primarily in Europe, that provides cloud-based AEMS along with cloud-based DMS (completed in 2019). Along with the start of this demonstration operation, an online ceremony to celebrate the start of operation was held connecting Slovenia with Tokyo, which involved parties attended from both countries.

For more information, visit https://www.hitachi.com/New/cnews/month/2021/11/211105a.html.

Copyright ©2021 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.